15 results
8-K
EX-99.1
VERV
Verve Therapeutics Inc
10 Nov 21
Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2021 Financial Results
6:56am
medicines. Backed by an expert team and a strong balance sheet, we stand well positioned to advance our gene editing therapies and fundamentally change
S-1
EX-10.11
kfzs7 tgml
28 May 21
IPO registration
4:04pm
S-1
EX-10.12
0610qpbsm5 2j
28 May 21
IPO registration
4:04pm
S-1
EX-10.13
tdfbkgqxnf jjv
28 May 21
IPO registration
4:04pm
S-1
EX-10.17
ya9ui lpu5km
28 May 21
IPO registration
4:04pm
S-1
EX-10.9
9cp0h
28 May 21
IPO registration
4:04pm
DRS
4nd3riup6458k 91us
16 Apr 21
Draft registration statement
12:00am
DRS
EX-10.10
daitb7mc
16 Apr 21
Draft registration statement
12:00am
DRS
EX-10.13
lqiv7s
16 Apr 21
Draft registration statement
12:00am
DRS
EX-10.12
mhha7banfleb9
16 Apr 21
Draft registration statement
12:00am
DRS
EX-10.14
hd6k26pam4h98 gaot
16 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next